<qa>  What is the feasibility of thalidomide in patients with asymptomatic, in- Determine the feasibility, in terms of toxicity and patient compliance, of thalidomide in patients with asymptomatic, indolent non-Hodgkins lymphoma or chronic lymphocytic leukemia. 